Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the MP Diagnostics HTLV Blot 2.4

NCT03146013 is registered in ClinicalTrials.gov with MP Biomedicals, LLC as lead sponsor.

NCT NCT03146013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03146013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the MP Diagnostics HTLV Blot 2.4
Lead sponsor
MP Biomedicals, LLC
Phase
Observational
Overall status
Completed
Start date
March 1, 2017
Completion date
May 31, 2017
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

htlv i associated myelopathies, htlv i associated t cell leukemia lymphoma, htlv-i infections, htlv-ii infections, human t-lymphotropic virus 1, human t-lymphotropic virus 2